Are Borrmann’s Types of Advanced Gastric Cancer Distinct Clinicopathological and Molecular Entities? A Western Study
Cristina Díaz del Arco(Universidad Complutense de Madrid), María Jesús Fernández‐Aceñero(Universidad Complutense de Madrid), Soledad García Gómez de las Heras(Universidad Rey Juan Carlos), Lourdes Estrada Muñoz(Universidad Rey Juan Carlos), M. Ángeles Cerón Nieto(Hospital Clínico San Carlos), Elena Molina Roldán(Hospital Clínico San Carlos), Luís Ortega(Universidad Complutense de Madrid)
Cited by 28
Related Papers
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)
|Annals of Oncology|2015|157
Clinical presentation and outcome across age categories among patients with COVID-19 admitted to a Spanish Emergency Department
|European Geriatric Medicine|2020|66
Eosinophilic colitis: Case series and literature review
|Pathology - Research and Practice|2017|43
Immunohistochemical classification of gastric cancer based on new molecular biomarkers: a potential predictor of survival
|Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin|2018|32
Molecular Classifications in Gastric Cancer: A Call for Interdisciplinary Collaboration
|International Journal of Molecular Sciences|2024|30